Type 2 & other diabetes

Incidence and risks of coronary heart disease and heart failure in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry

Diabetes Res Clin PractPublished Prospective cohort study

Authors' conclusion

The incidence of heart disease was low and circulating adiponectin and sarcopenia may predict the development of heart disease in Japanese patients with type 2 diabetes.

Study context

Population
Japanese outpatients with T2D registered at multicenter diabetes clinics of a prefecture, 2008–2010 (mean age 65 years, male 57%, previous coronary heart disease (CHD) 14%)follow-up rate 98%
Participants
4,874 outpatients
Outcome
Incidence of CHD and HF requiring hospitalization
Follow-up
Median 5.3 years
Methodological detailsmulticenter, registry
  • Multicenter
  • Registry

Main finding

As reported in the abstract

Incidence rates per 1,000 person-years
CHD
12.3
Silent myocardial ischemia
5.8
Angina pectoris
4.3
MI
2.1
Hospitalized heart failure (HF)
3.1

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Risk factors for new-onset CHD (multivariable adjusted Cox)Highest quartile serum adiponectinvs Lowest quartile serum adiponectin1.6 (1.0–2.6)
Risk factors for HF (multivariable adjusted Cox)Highest quartile serum adiponectinvs Lowest quartile serum adiponectin2.4 (1.1–5.2)
Risk factors for HF (multivariable adjusted Cox)Lowest quartile serum creatinine/cystatin C ratiovs Highest quartile serum creatinine/cystatin C ratio4.6 (1.9–11.1)
  • Risk factors for HF (multivariable adjusted Cox): creatinine/cystatin C ratio is a surrogate marker for sarcopenia

Original publication

Incidence and risks of coronary heart disease and heart failure in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry. Diabetes Res Clin Pract. Published 26 May 2023. doi:10.1016/j.diabres.2023.110732

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.